Cushing's syndrome resident survival guide: Difference between revisions
Jump to navigation
Jump to search
MydahSajid (talk | contribs) |
MydahSajid (talk | contribs) |
||
Line 83: | Line 83: | ||
{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{familytree | | | | | | | | A01 |A01= The treatment depends upon the underlying etiology }} | {{familytree | | | | | | | | A01 |A01= The treatment depends upon the underlying etiology }} | ||
{{familytree | | | |,|-|-|-|-|+|-|-|-|-|. | {{familytree | | | |,|-|-|-|-|+|-|-|-|-|-|.| | }} | ||
{{familytree | | |B01| | | | | {{familytree | | |B01| | |B02| | | | | |B03| |B01= [[Cushing's disease]] |B02= Paraneoplastic [[Cushing's syndrome]] |B03= ACTH-independent [[Cushing's syndrome]] }} | ||
{{familytree | | | |!| | |,|-|^|-|.| |,|-|^|-|.| }} | {{familytree | | | |!| | |,|-|^|-|.| |,|-|^|-|.| }} | ||
{{familytree | | |C01| |C02| | |C03| |C04| |C05| C01= Transsphenoidal surgery: Treatment of choice in patients with [[pituitary]] adenoma with distinct margins. | C02= Resectable tumor | C03= Nonresectable tumor | C04= Adrenal adenomas | C05= Bilateral adrenal hyperplasia }} | {{familytree | | |C01| |C02| | |C03| |C04| |C05| C01= Transsphenoidal surgery: Treatment of choice in patients with [[pituitary]] adenoma with distinct margins. | C02= Resectable tumor | C03= Nonresectable tumor | C04= Adrenal adenomas | C05= Bilateral adrenal hyperplasia }} |
Revision as of 14:11, 19 August 2020
Resident Survival Guide |
---|
Introduction |
Team |
Guide |
Page Template |
Examine the Patient Template |
Navigation Bar Template |
Checklist |
Topics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
This section provides a short and straight to the point overview of the disease or symptom. The first sentence of the overview must contain the name of the disease.
Causes
Life Threatening Causes
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
- Does not include any known cause.
Common Causes
- Iatrogenic or factitious Cushing's syndrome due to administration of exogenous glucocorticoids.
- Cushing's disease (due to excess secretion of Adrenocorticotropic hormone [ACTH] from anterior pituitary).
- Paraneoplastic: due to ectopic secretion of ACTH (includes, small cell lung cancer, benign carcinoid tumors, Ewing's sarcoma).
- Ectopic secretion of Corticotropin-releasing hormone (CRH).
- Adenoma and carcinoma in the adrenal cortex
- Primary pigmented nodular adrenocortical disease (PPNAD)
- Bilateral macronodular adrenal hyperplasia (BMAH)
Diagnosis
Shown below is an algorithm summarizing the diagnosis of Cushing's syndrome according to the Endocrine Society clinical guidelines.
Symptoms suggestive of Cushing’s syndrome:
| |||||||||||||||||||||||||||||||||||||
Take a detailed history of the patient including medication history. Rule out the use of any exogenous topical, oral, parenteral, or inhaled glucocorticoid and synthetic progesterone. | |||||||||||||||||||||||||||||||||||||
Perform any two of the following three laboratory investigations:
| |||||||||||||||||||||||||||||||||||||
Two of the following abnormal results:
| Any one abnormal result | ||||||||||||||||||||||||||||||||||||
High suspicion for Cushing's syndrome | Low suspicion for Cushing's syndrome | ||||||||||||||||||||||||||||||||||||
Measure late night plasma ACTH levels | Refer to endocrinologist | ||||||||||||||||||||||||||||||||||||
Low value plasma ACTH <5 pg/mL | Indeterminate values of plasma ACTH between 5 to 20 pg/mL | High value plasma ACTH >20 pg/mL | |||||||||||||||||||||||||||||||||||
CRH or desmopressin stimulation test | |||||||||||||||||||||||||||||||||||||
No ACTH response | + ACTH response | ||||||||||||||||||||||||||||||||||||
ACTH independent Cushing's syndrome | ACTH dependent Cushing's syndrome | ||||||||||||||||||||||||||||||||||||
CT scan/ MRI of adrenal glands to look for adrenal tumors or hyperplasia. | Perform both tests:
| ||||||||||||||||||||||||||||||||||||
Adequate suppresion of early morning serum cortisol (with levels less than 5 mcg/dL) and stimulation with CRH | Negative or equivocal response | ||||||||||||||||||||||||||||||||||||
MRI of the pituitary | |||||||||||||||||||||||||||||||||||||
Tumor >6mm | Tumor <6mm or no mass lesion | ||||||||||||||||||||||||||||||||||||
Cushing's disease | Perform Inferior petrosal sinus sampling. | ||||||||||||||||||||||||||||||||||||
Central step-up | No Central step-up | ||||||||||||||||||||||||||||||||||||
Ectopic ACTH production | |||||||||||||||||||||||||||||||||||||
Treatment
Shown below is an algorithm summarizing the treatment of Cushing's syndrome according the the Endocrine Society clinical practice guidelines.
{{familytree/end}
Do's
- The content in this section is in bullet points.
Don'ts
- The content in this section is in bullet points.
References
The treatment depends upon the underlying etiology | |||||||||||||||||||||||||||||||||||||||||||
Cushing's disease | Paraneoplastic Cushing's syndrome | ACTH-independent Cushing's syndrome | |||||||||||||||||||||||||||||||||||||||||
Transsphenoidal surgery: Treatment of choice in patients with pituitary adenoma with distinct margins. | Resectable tumor | Nonresectable tumor | Adrenal adenomas | Bilateral adrenal hyperplasia | |||||||||||||||||||||||||||||||||||||||
Pituitary irradiation carried out in patients with:
| Bilateral adrenalectomy is carried out in patients with severe refractory hypercortisolism. | Resection of the primary tumor | Unilateral adrenalectomy | Bilateral adrenalectomy | |||||||||||||||||||||||||||||||||||||||